Ignite Creation Date:
2024-05-06 @ 6:00 PM
Last Modification Date:
2024-10-26 @ 2:39 PM
Study NCT ID:
NCT05500807
Status:
RECRUITING
Last Update Posted:
2023-03-01
First Post:
2022-08-12
Brief Title:
Emicizumab for Severe Von Willebrand Disease VWD and VWDHemophilia A
Sponsor:
Bleeding and Clotting Disorders Institute Peoria Illinois
Organization:
Bleeding and Clotting Disorders Institute Peoria Illinois
Organization Data
Organization:
Bleeding and Clotting Disorders Institute Peoria Illinois
Class:
OTHER
Study ID:
BCDI-XII
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Bleeding and Clotting Disorders Institute Peoria Illinois
Lead Sponsor Class:
OTHER
Responsible Party:
Jonathan Roberts
Responsible Party Title:
Assistance Medical Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Bleeding and Clotting Disorders Institute Peoria Illinois
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |